We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Breast Imaging Diagnostic Workstation Provides Full Synapse PACS Capabilities

By MedImaging staff writers
Posted on 22 Jul 2008
Print article
Available for facilities that have implemented full-field digital mammography (FFDM), a new breast imaging diagnostic workstation (BIDW) has been developed especially to complement a computed radiography for mammography (FCRM) system and provide better workstation interpretation capabilities for facilities that may use another vendor's picture archiving and communication systems (PACS).

Developed by Fujifilm Medical Systems USA, Inc. (Stamford, CT, USA), the system provides full Synapse PACS functionality. This new standalone workstation is designed to be a supplement to any facility's existing PACS, and meet the need for more clinically and operationally advanced systems to support breast imaging.

"As more and more facilities adopt digital mammography, there is an increased need for PACS that provide the specialized features and advanced technologies that are so vital to the interpretation of full field digital mammography exams,” explained Jim Morgan, Fujifilm's director of network systems. "Synapse is an advanced PACS that is uniquely capable of providing the diagnostic and clinical tools that radiologists demand for FFDM. The breast imaging diagnostic workstation will now enable customers that might already have an existing PACS to benefit from full Synapse capabilities and additional features specifically designed for digital mammography when interpreting their FFDM studies.”

Fujifilm's BIDW was designed with not only clinical, but operational and integration needs in mind. In addition to providing Fujifilm's image quality, it also offers the ability to support computer-aided detection (CAD), MQSA (Mammography Quality Standards Act of 1992) overlays, and provides Fujifilm's patented reading protocol technology for efficient reading workflow. Upon image acquisition all FFDM studies are automatically sent to the BIDW, where image display is available in seconds and prior studies can be accessed for comparison, all ensuring optimal operational efficiency is maintained for radiologists. This functionality is not limited to breast imaging, because it is Synapse PACS. Furthermore, the BIDW can be completely integrated with all other radiology systems, including any mammography specific reporting systems, radiology information systems (RIS), and PACS.

FujiFilm Medical Systems USA is a leading provider of diagnostic imaging products and network systems to meet the needs of healthcare facilities. Fujifilm's Synapse PACS provides a system for managing, storing, and distributing images and information throughout the entire healthcare enterprise. Its Web-integrated design and hardware-independence provide a technologic infrastructure and deployment model that can be expanded upon in a host of ways to adapt to evolving technologies.


Related Links:
Fujifilm Medical Systems USA
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Mammography Analytics Platform
Unifi Analytics Software
Ultrasound Color LCD
U156W
New
Table-Top Reader
FCR PRIMA T2

Print article

Channels

MRI

view channel
Image: The AI algorithm analyzes MRI scans to better understand how rectal tumors respond to treatment (Photo courtesy of 123RF)

AI Algorithm Analyzes MRI Scans to Determine Best Rectal Cancer Treatment Strategy

Rectal cancer patients typically follow a standardized treatment protocol that often requires surgery, which carries risks and potential complications, including a reduced quality of life.... Read more

Ultrasound

view channel
Image: The composite hydrogel enables sustained and consistent drug release, triggered by ultrasound (Photo courtesy of Journal of Controlled Release; DOI: 10.1016/j.jconrel.2024.08.001)

Ultrasound-Activated Hydrogel Could Revolutionize Drug Delivery for Medical Applications

Researchers have created a composite hydrogel that enables sustained and consistent drug release, triggered by ultrasound. This breakthrough could transform drug delivery for numerous medical applications... Read more

Nuclear Medicine

view channel
Image: A new biomarker makes it easier to distinguish between Alzheimer’s and primary tauopathy (Photo courtesy of Shutterstock)

Diagnostic Algorithm Distinguishes Between Alzheimer’s and Primary Tauopathy Using PET Scans

Patients often present at university hospitals with diseases so rare and specific that they are scarcely recognized by physicians in private practice. Primary 4-repeat tauopathies are a notable example.... Read more

Industry News

view channel
Image: Focused ultrasound therapy is poised to become an essential tool in every hospital, cancer care center and physician office (Photo courtesy of Arrayus)

Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer

Pancreatic cancer remains one of the most difficult cancers to treat due to its dense tissue structure, which limits the effectiveness of traditional drug therapies. Bracco Imaging S.A. (Milan, Italy)... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.